Reference 2019-28

REF:           2019-28

Subject:       Ophthalmology injections and implants

 

Request:

Within your Trust how many Intra-vltreat Injections / Implants have been used in the latest 4 months, if possible between September and December ’18.

If your Trust is able to identify Injections / Implants by eye conditions please split by the drug used (Ranibizumab, Bevacizumab, Aflibercept, Fluocinolone and Dexamethasone)

 

 

Response:

Injections / implants

Total

Lucentis (Ranibizumab) Injections

871

Avastin (Bevacizumab) Injections

3

Eylea (Aflibercept) Injections

1098

Illuvieb (Fluocinolone) Implants

0

Ozudex (Dexamethasone) Implants

9

Please note that we are unable to provide figures for individual eye conditions (Wet Age Related Macular Degeneration (wAMD); Diabetic Macular Oedema (DMO); Retinal Vein Occlusion – Central or Branch (CRVO or BRVO); Other e.g. mCNV) only totals.